PR on Friday February 28 ALT https://finance.yahoo.com/quotes/alt Altimmune Completes First Development Milestone Toward a Single-Dose Intranasal COVID-19 Vaccine https://www.globenewswire.com/news-...-Single-Dose-Intranasal-COVID-19-Vaccine.html
PR Wednesday March 4 Arcturus Therapeutics and Duke-NUS Medical School Partner to Develop a Coronavirus (COVID-19) Vaccine using STARR Technology™ http://ir.arcturusrx.com/news-relea...rapeutics-and-duke-nus-medical-school-partner https://finance.yahoo.com/quote/ARCT?p=ARCT .
BIOC https://www.marketwatch.com/story/b...e-offering-prices-at-deep-discount-2020-03-02 "Biocept Announces Pricing of $9.2 Million Registered Direct Offering Priced At-The-Market" https://finance.yahoo.com/news/biocept-announces-pricing-9-2-133000763.html 23 million shares at $0.40 69,673,243 shares prior to offering .
Another PR from HTBX on March 5: https://ir.heatbio.com/press-releas...ologics-announces-research-collaboration-with "Heat Biologics Announces Research Collaboration with University of Miami to Develop Vaccine Designed to Protect Against COVID-19 Coronavirus" https://ir.heatbio.com/
Thursday Match 5 OPK https://finance.yahoo.com/quotes/opk "OPKO Health's BioReference Laboratories to Introduce Coronavirus Disease (COVID-19) Test" https://www.opko.com/investors/news...ealths-bioreference-laboratories-to-introduce Opko Health up 12% on planned launch of coronavirus testing service https://seekingalpha.com/news/35491...planned-launch-of-coronavirus-testing-service
Friday March 6 ENZ https://finance.yahoo.com/quotes/enz http://www.enzo.com/corporate/investor-information http://www.enzo.com/corporate/press-releases "Enzo Biochem’s Full Service Clinical Laboratory to Launch Coronavirus (COVID-19) Testing Services Next Week" http://www.enzo.com/corporate/press...ronavirus-covid-19-testing-services-next-week https://finance.yahoo.com/news/enzo-biochem-full-clinical-laboratory-130000360.html .
https://finance.yahoo.com/quotes/aim,novn "AIM ImmunoTech’s Drug Ampligen to Be Tested by Japan’s National Institute of Infectious Diseases as a Potential Treatment for the New SARS Coronavirus (SARS-CoV-2) Responsible for the New Human Infectious Disease COVID-19" NOVN https://twitter.com/search?f=live&vertical=default&q=$novn